Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.

about

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.

P2860

Q44852748-C37113AB-157F-4719-A432-FAF84E5E73C7 Q47548498-628E999C-2EC0-427F-BD91-9AF3A3677CE3

P2860

Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.

Item

http://www.wikidata.org/entity/Q38762019

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of IgG Fc-Oligosacchari ...... ability, Safety, and Efficacy.

@en

type

Item

label

Impact of IgG Fc-Oligosacchari ...... ability, Safety, and Efficacy.

@en

prefLabel

Impact of IgG Fc-Oligosacchari ...... ability, Safety, and Efficacy.

@en

P1476

Impact of IgG Fc-Oligosacchari ...... tability, Safety, and Efficacy

@en

P2093

Alyssa Neill

http://www.w3.org/2001/XMLSchema#string

Bruce Andrien

http://www.w3.org/2001/XMLSchema#string

Christine Nowak

http://www.w3.org/2001/XMLSchema#string

Gomathinayagam Ponniah

http://www.w3.org/2001/XMLSchema#string

Mei Shao

http://www.w3.org/2001/XMLSchema#string

P2860

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins

Fc glycans of therapeutic antibodies as critical quality attributes

In vitro and in vivo modifications of recombinant and human IgG antibodies

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

The structure of a human type III Fcgamma receptor in complex with Fc

Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1

P304

1173-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BTPR.2498

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hongcheng Liu

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28547754

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide

Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.

about

P2860

P2860

Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921